SEC 13F Intelligence

Rock Springs Capital Management LP / TVTX

Rock Springs Capital Management LP’s Travere Therapeutics Inc Position

Does Rock Springs Capital Management LP own Travere Therapeutics Inc (TVTX)? Yes1.48M shares worth $44M (+2.59% of its 13F portfolio) as of Q1 2026, down from 2.21M shares the prior filed quarter.

Position Value
$44M
Q1 2026
Shares
1.48M
% of Portfolio
+2.59%
Quarters Held
22
currently held

Position History TVTX

Reported value by quarter
Q4 ’20: $28MQ4 ’20Q1 ’21: $37MQ2 ’21: $22MQ3 ’21: $36MQ3 ’21Q4 ’21: $30MQ1 ’22: $25MQ2 ’22: $23MQ2 ’22Q3 ’22: $23MQ4 ’22: $20MQ1 ’23: $29MQ1 ’23Q2 ’23: $23MQ3 ’23: $16MQ4 ’23: $25MQ4 ’23Q1 ’24: $26MQ2 ’24: $37MQ3 ’24: $66MQ3 ’24Q4 ’24: $87MQ1 ’25: $52MQ2 ’25: $28MQ2 ’25Q3 ’25: $52MQ4 ’25: $84MQ1 ’26: $44MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.48M$44M+2.59%
Q4 20252.21M$84M+4.33%
Q3 20252.16M$52M+3.02%
Q2 20251.91M$28M+1.76%
Q1 20252.92M$52M+3.00%
Q4 20244.97M$87M+3.30%
Q3 20244.68M$66M+2.13%
Q2 20244.48M$37M+1.11%
Q1 20243.42M$26M+0.67%
Q4 20232.77M$25M+0.61%
Q3 20231.81M$16M+0.43%
Q2 20231.53M$23M+0.56%
Q1 20231.28M$29M+0.69%
Q4 2022951.6K$20M+0.48%
Q3 2022951.6K$23M+0.61%
Q2 2022951.6K$23M+0.67%
Q1 2022951.6K$25M+0.62%
Q4 2021951.6K$30M+0.68%
Q3 20211.50M$36M+0.76%
Q2 20211.49M$22M+0.43%
Q1 20211.48M$37M+0.80%
Q4 20201.02M$28M+0.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of TVTX.